PPW
ABBV icon

Pinnacle Private Wealth’s AbbVie ABBV Stock Holding History

Pinnacle Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$646K Sell
4,218
-208
-5% -$31.8K 0.25% 93
2022
Q1 		$717K Sell
4,426
-3,612
-45% -$525K 0.22% 101
2021
Q4 		$1.09M Buy
+8,038
New +$949K 0.34% 71

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pinnacle Private Wealth's ABBV Position: Q2 2022 in Review

Pinnacle Private Wealth reduced its AbbVie (ABBV) stake by 4.7% in Q2 2022, selling an estimated $31.8K and leaving 4,218 shares worth $646K. The position accounts for 0.25% of the portfolio, ranked #93.

Pinnacle Private Wealth first reported a position in ABBV in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.09M in Q4 2021. 3,006 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Pinnacle Private Wealth held 4,218 shares of AbbVie worth $646K as of Q2 2022.
  • Pinnacle Private Wealth sold 208 AbbVie shares in Q2 2022, an estimated $31.8K.
  • AbbVie made up 0.25% of Pinnacle Private Wealth's portfolio in Q2 2022, its #93 holding.
  • Pinnacle Private Wealth first reported a position in AbbVie in Q4 2021 and has held it in 3 quarters since.
  • Pinnacle Private Wealth's AbbVie position peaked at $1.09M in Q4 2021.
  • 3,006 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Pinnacle Private Wealth's 13F filing for Q2 2022, filed 15 Jul 2022.